Chronic kidney disease-associated pruritus (CKD-aP) Program in Pharmaceutical Benefits Scheme (PBS) 012-24041207
This document outlines details of PBS-subsidised difelikefalin (pronounced “dye-fel-i-KEF-a-lin”) for patients with chronic kidney disease-associated pruritus (CKD-aP).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.